Enterprise Risk Management Overview Ernst & Young LLP ERM: Basic Elements • Global Focus – Pricing risk – Operational Risk • Suitability of accounting treatment – Reflecting.

Download Report

Transcript Enterprise Risk Management Overview Ernst & Young LLP ERM: Basic Elements • Global Focus – Pricing risk – Operational Risk • Suitability of accounting treatment – Reflecting.

Enterprise Risk Management
Overview
Ernst & Young LLP
ERM: Basic Elements
• Global Focus
– Pricing risk
– Operational Risk
• Suitability of accounting treatment
– Reflecting real earnings
– Matching revenue to risk
• Common framework comparing different types of risks
– Determining impact of different kinds of risk
– “Extreme Risk”
Enterprise Risk Management for Health Entities
Slide 2
How Relevant to Health Industry ?
• More Homogenous Risk
– Less dramatic “extreme risk”
– “Death of a thousand cuts”
• Little ALM Impact
– Cash In – Cash Out
– Short tail without much investment-supported pricing
• Extremely wide variety of unknowns
– Market, economy, regulation, providers, contractual, business
– Common excuse for simple view is actually its extreme complexity
Enterprise Risk Management for Health Entities
Slide 3
How Relevant ?
Example of Extreme P&C Risk
Catastrophic
Event
Calls on
Assets
Cash Flow
Impairment
Cost of
Capital Rises
Possible Health Carrier Version
Understate
IBNP
Miss Pricing
& Earnings
Earnings &
Surplus Drop
Enterprise Risk Management for Health Entities
Cost of
Capital Rises
Slide 4
How Relevant : Current Observations
• Recent Results – Favorable to Very Favorable
• Challenges – Even in Favorable Times
– Observations by Regulators and/or Boards
– Public – Profits coincident with Premium Increases
– Using Capital Wisely?
• Anticipated Future Challenges
– Responses to Affordability
– Product/Network Development
– Administrative Costs – Lower Premium Base
• How structured are carrier processes and abilities to
measure and articulate the risks they face?
Enterprise Risk Management for Health Entities
Slide 5
Health Processes : Current Observations
• Traditional viewpoint – essentially pricing risk
– Business risk, operations, business continuation not linked except by RBC
– Soft linkage on items like acquisitions or new ventures
• Risks tend to be more homogenous
– RBC-based measurement is becoming a common tool
– Loosely quantified capital and vitality needs, short horizon timeframe
• Risk-Reward Trade-offs
– Product-specific targets - approximates pricing credibility
– Steered by broad market consensus or anecdotal competitive limitation
– Surplus contribution tends to be budget-based
• Budgeting and Projection Process
– Static or Deterministic – at best, some scenarios considered
– Function of volume, trended costs, and bottom line
– Target-driven cycle – adjust volume and price until “acceptable”
Enterprise Risk Management for Health Entities
Slide 6
Benchmarking: Surplus Levels
RBC Levels - Top 20 Carriers
60.0%
Distribution of Companies
50.0%
40.0%
30.0%
20.0%
10.0%
0.0%
< 1.0
1.0 - 2.0
2.0 - 3.0
3.0 - 4.0
4.0 - 5.0
5.0 - 6.0
6.0 - 7.0
7.0 - 8.0
> 8.0
Ratio to ACL
1998
1999
2000
2001
Enterprise Risk Management for Health Entities
Slide 7
Benchmarking: Surplus Levels
RBC Levels - BCBS Plans
35.0%
Distribution of Companies
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
< 1.0
1.0 - 2.0
2.0 - 3.0
3.0 - 4.0
4.0 - 5.0
5.0 - 6.0
6.0 - 7.0
7.0 - 8.0
> 8.0
Ratio to RBC
1998
1999
2000
2001
Enterprise Risk Management for Health Entities
Slide 8
Realized U/W Profits – Top 20 Carriers
Underwriting Gains - Top 20 Carriers
60.0%
Distribution of Companies
50.0%
40.0%
30.0%
20.0%
10.0%
0.0%
< -8%
-8% to -5%
-5% to -3%
-3% to -1%
-1% to 1%
1% to 3%
3% to 5%
5% to 8%
> 8%
% of Revenue
1997
1998
1999
2000
2001
Enterprise Risk Management for Health Entities
Slide 9
Realized U/W Profits – BCBS Plans
Underwriting Gains -- BCBS Plans
45.0%
40.0%
Distribution of Companies
35.0%
30.0%
25.0%
20.0%
15.0%
10.0%
5.0%
0.0%
< -8%
-8% to -5%
-5% to -3%
-3% to -1%
-1% to 1%
1% to 3%
3% to 5%
5% to 8%
> 8%
% of Revenue
1997
1998
1999
2000
2001
Enterprise Risk Management for Health Entities
Slide 10
Expanding the Dialogue - Pressures
• Targets
– Data suggest some implied target – greater than RBC
– Profit targets roughly linked to building surplus
• Capital Markets
– Cheap debt is buying some time as well
– Europe / Banking has moved to Economic Capital
– Life and P&C Carriers starting RAROC
– Analyst and market considerations
• Process
– Above measures force more analytical linkages
– Improving the credibility of the planning process
– Need to recognize unique Health Industry requirements
Enterprise Risk Management for Health Entities
Slide 11
Expanding the Dialogue
• Surplus
– Broader recognition of risk / reward mix
– Better quantification of viability and capital needs
– Rationalization / Justification of surplus needs
• Health Profit Targets
– Improved risk-reward equation by product
– Required surplus contribution should be risk-based
• Budgeting and Projections Process
– Improving the linkage between capital needs and budget targets
– Stochastic modeling – potentially RAPM / RAROC
• Return
– % of Premium still OK – may be converted from other measures
– ROI target “denominator” --- RBC, Economic Capital
Enterprise Risk Management for Health Entities
Slide 12
Capital and Surplus Management for
Health Entities
Surplus and Appropriate Returns
Benchmarking: RBC Measurement
Market/Asset
Liability
Management
Risk
H3
H1
Underwriting
Risk
Credit Risk
• Asset Devaluation
• Asset Concentration
Operational /
• Reinsurance
• Capitation
• Receivables
Business Risk
H4
H2
• Admin Risk
• Rapid Growth
• ASO
• Product Specific Risk
• Managed Care Credit
• Rate Guarantees
H0
• Interest in Affiliates
H 0  H1  H 2  H 3  H 4
2
Enterprise Risk Management for Health Entities
2
2
Slide 14
2
Using RBC to define Risk/Return
• Capital allocation was not among the RBC
development goals
• Positive Aspects
– Commonly accepted base
– Ruin Theory with Monte Carlo simulations
– Recognizes specific risk elements
• Issues
– Broadly based factors = “average”
– Some political compromise
– Observations imply target is some multiple of RBC floor
Enterprise Risk Management for Health Entities
Slide 15
Alphabet Soup: Measures and Metrics
• Economic Value Added (EVA)
– Rate of return versus cost of capital
– Not a ratio, converted into % for planning
– Often a multi-year projection of results
• Dynamic Financial Analysis (DFA)
– Stochastic modeling - P&C Carriers
– Typically multi-year proposition with emphasis on asset impacts
• Return on Equity ( ROE or ROI )
– Question is --- what is the denominator ?
– RBC can work – at least based on ruin theory
– RBC is a broad measurement of risk by product
• Risk-Adjusted Return on Capital (RAROC / RAPM)
– Economic Income / Economic Capital
– Requires some form of modeling of risks assumed
– Works well when comparing diverse lines of business
Enterprise Risk Management for Health Entities
Slide 16
Using Economic Capital for Risk / Return
• Positive Aspects
– Specifically addresses business risks for the carrier
– Comparing lines of business or new ventures
– Can directly tie budgeting process to surplus needs
– Possible emerging standard in other sectors
• Issues
– Can require more sophisticated modeling
– Judgment calls on some factors and distributions
– Not yet commonly accepted approach
Enterprise Risk Management for Health Entities
Slide 17
Economic Capital or RAROC Measures
Market/Asset
Liability
Management
Risk
Underwriting
Risk
•
•
•
•
•
•
•
• Changes in interest rates
• Equities Volatility
• Fixed income Volatility
Credit Risk
• Default risk
Operational /
Business Risk
•
•
•
•
•
•
•
•
•
•
Medical trend volatility
Lapse
Mortality
Morbidity
Catastrophic
Reserve volatility
Multi-option choice
Enterprise Risk Management for Health Entities
Litigation
Disaster recovery
Claim fraud
Market conduct
Claim rework costs
New competitors
New products
Regulatory
Tax law changes
Capitation Issues
Slide 18
Measuring Economic Capital
Probability of loss
LOB A
LOB B
Earnings
Earnings
Uniform risk
(e.g., 99.75%)
Uniform risk
(e.g., 99.75%)
Zero
losses
0%
Expected
level of
loss
Potential “unexpected”
losses requiring capital
for LOB A
Loss rate
Potential “unexpected”
losses requiring capital
for LOB B
100%
0%
Enterprise Risk Management for Health Entities
Loss rate
100%
Slide 19
Economic Capital or RAROC Measures
Underwriting
Risk
•
•
•
•
•
•
•
Factors modeled using
stochastic outcomes
Medical trend volatility
Lapse
Mortality
Morbidity
Catastrophic
Reserve volatility
Multi-option choice
Enterprise Risk Management for Health Entities
Slide 20
Expanding the Dialogue – Linkages
Premium
Investment
Income
Balance
Sheet
Surplus
Benefits
Solvency
Investment
Expenses
Taxes
Viability
External
Capital
Service
Improvement
Contribution to Surplus
Enterprise Risk Management for Health Entities
Slide 21
Linking the Pieces
Budgeting
RBC “ + ”
Surplus
Capital
Allocation RAROC
Premium
Investment Income
Regulatory
Benefits
Capital Costs
Admin Expenses
Taxes
Investment
Capital
Budget
Strategic
Plan
Viability
Contribution to Surplus
Enterprise Risk Management for Health Entities
Slide 22